JPRN-UMIN000022988
Completed
未知
Combination therapy of intravitreal aflibercept and topical bromfenac for RVO - Combination therapy of IVA and bromfenac
Juntendo Urayasu Hospital0 sites40 target enrollmentAugust 1, 2016
Conditionsretinal vein occlusion
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- retinal vein occlusion
- Sponsor
- Juntendo Urayasu Hospital
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) The patient who has difficulty in periodical going to hospital. 2\)The patients who have had vitrectomy surgery or anti\-VEGF injection. 3\)The patient who received intraocular operation within three months before first injection. 4\)The patient that it was judged to be inappropriate as an object of this study. 5\)The patients who had other disease which induce visual disorder.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
To investigate the role of Intravitreal Aflibercept (Eylea) in the treatment of patients whose wet Age related Macular degeneration is not adequately controlled with conventional anti VEGF (intravitreal Avastin or Lucentis) treatment.ACTRN12613001020774Greenlane Clinical Centre Auckland District Health Board50
Completed
Phase 4
The study of Intravitreal aflibercept with treat and extend regimen for macular edema with branch retinal vein occlusion (BRVO)Branch retinal vein occlusionJPRN-UMIN000023200Department of Ophthalmology, Akita University50
Completed
Not Applicable
Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularizatioSubfoveal type 2 choroidal neovascularizationJPRN-UMIN000016870agoya City University Graduate School of Medicine20
Recruiting
Not Applicable
Treat and extend regimens with intravitreal aflibercept for macular edema secondary to branch retinal vein occlusiobranch retinal vein occlusionJPRN-UMIN000027005Jikei daisan hospital50
Not yet recruiting
Not Applicable
Effect of Alternate Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor and Corticosteroid for Macular EdemaKCT0007766Hallym University Medical Center-Kangnam188